The purpose of this study is to determine if clopidogrel inhibits hepatic uptake transport of rosuvastatin clinically.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
10
Rosuvastatin 20 mg PO x 1
Clopidogrel 300 mg PO x 1 (30 minutes prior to rosuvastatin dose); Clopidogrel 75 mg PO x 1 (24 hours post-rosuvastatin dose)
Clinical Research Center, UCSF
San Francisco, California, United States
Area-under-the-concentration curve (AUC) of rosuvastatin
Time frame: Blood samples collected over a 48 hour period
Maximum plasma concentration (Cmax) of rosuvastatin
Time frame: predose, 0, 0.5, 1, 1.5, 2, 3, 4, 6, 9, 12, 24, 36, and 48 hours post-dose
Time to concentration maximum (Tmax) of rosuvastatin
Time frame: predose, 0, 0.5, 1, 1.5, 2, 3, 4, 6, 9, 12, 24, 36, and 48 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.